Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Identify the best credit cards with travel rewards to enhance your travel plans. Discover cards that fit your travel lifestyle.
14,181 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Palantir has cooled off after a blazing run, but analysts say there's still meaningful upside. This guide breaks down...
General Dynamics posted a strong first quarter, while Lockheed Martin unveiled a major Ultra Maritime purchase, sharp...
As an upcoming investor update looms, you may wonder if you should microsoft stock be before the news. This guide bre...
Intel stock has moved faster than its turnaround plan in many eyes. As Lip-Bu Tan reshapes the company, investors mus...
Digital health is redefining care delivery and costs. This guide shows how to find a high-growth healthcare stock ear...
Private exits are lagging as liquidity tightens in private markets. This report explains why the exploding secondarie...
As AI builds demand for data centers, most giants plow assets into expansion. One tech leader bucking the trend could...
Viking Holdings (VIK) 2025 reveals how the company navigated a mixed year. This analysis breaks down Q4 results, marg...
DTI's 2025 earnings narrative sheds light on demand for drilling tools and oilfield equipment. This guide breaks down...
Two AI infrastructure players, CoreWeave and Nebius, face off as compute demand climbs. This guide breaks down backlo...
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...